Pfizer Shares Among These Healthcare Stocks Downgraded

Wall St. Watchdog reveals information about companies for which stock analysts downgraded shares in the Healthcare sector for the week ending November 4th, 2011:

  • Pfizer (NYSE:PFE): Standpoint Research downgraded its rating on this company from Buy to Hold on Nov 1st. The shares recently traded at $20.07, up $0.74, or 3.83% since the analyst’s rating. About the company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines. Get the most recent company news and stock data here >>
  • NuVasive (NASDAQ:NUVA): Rodman & Renshaw downgraded its rating on this company from Mkt Outperform to Mkt Perform on Nov 1st. The shares recently traded at $14.84, up $0.81, or 5.77% since the analyst’s rating. About the company: NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company’s products include Maximum Access Surgery and Fusion products. Get the most recent company news and stock data here >>
  • Amyris (NASDAQ:AMRS): Robert W. Baird downgraded its rating on this company from Outperform to Neutral and changed its price target from $25 to $16 on Nov 2nd. The shares recently traded at $13.45, down $2.02, or 13.06% since the analyst’s rating. About the company: Amyris, Inc. is a renewable products company. The Company provides alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Amyris is developing Brazilian sugarcane as its primary feedstock. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>